Table 2 Patient clinical characteristics
Patient | Number of active joints Dx | Number of active joints FTx | CRP (mg/l) Dx | CRP (mg/l) FTx | cJADAS10 Dx | cJADAS10 FTx | NETs (%) Dx | NETs (%) FTx | NE activity (mU) Dx | NE activity (mU) FTx | MPO activity (U) Dx | MPO activity (U) FTx |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oligo 1 | 2 | 0 | 0.06 | 0.14 | 14 | 3 | 70.5 | 34.3 | 8.3 | 6.6 | 1.17 | 1.36 |
Oligo 2 | 1 | 1 | 18.00 | 0.20 | 13 | 6 | 88.3 | 59.6 | 15.9 | 4.7 | 1.72 | 1.37 |
Oligo 3 | 1 | 0 | 1.62 | 0.03 | 3 | 0 | a | 27.5 | 3.3 | 4.9 | 0.80 | 0.29 |
Oligo 4 | 1 | 2 | 12.00 | 7.00 | 9 | 5 | 43.2 | 36.0 | 13.9 | 16.4 | 1.03 | 1.01 |
Poly 1 | 5 | 0 | 4.50 | 0.71 | 18 | 0 | 44.4 | 93.8 | 9.7 | 12.8 | 1.76 | 0.42 |
Poly 2 | 8 | 9 | 78.00 | 20.00 | 17 | 18 | 31.5 | 88.0 | 6.4 | 11.3 | 0.77 | 0.54 |
Poly 3 | 5 | 5 | 37.00 | 20.04 | 11 | 20 | 35.9 | 44.6 | 5.3 | 5.0 | 0.39 | 1.48 |